COMPANY PHILOSOPHY

We offer less-invasive and non-invasive endoscopes and other medical devices, thereby provide gentle remedies to patients and medical staffs. We are proud of our products that help saving lives and fighting diseases. Our mission is to contribute to society emphasizing our ultra-thin endoscope know-how and utilizing "Tsunagu" Technologies amongst human lives.

  • SAKURA Research Center
  • FiberTech Co.,Ltd.

BACK to TOP

ABOUT US

Company Name
FiberTech Co., Ltd.
Locations

Head Office

Sakura Research Center, 409-1 Nishimikado, Sakura-shi, Chiba 285-0074, JAPAN

Phone: +81-43-481-5381

Facsimile: +81-43-498-4575


Tokyo Office

8F, Nishikicho MK Bldg., 3-23, Kanda-Nishikicho, Chiyoda-ku
Tokyo 101-0054, JAPAN

Phone: +81-3-5259-7600

Facsimile: +81-3-5259-1155


Applied Optics Center

c/o Fujikura Ltd., 1440 Mutsuzaki, Sakura-shi, Chiba 285-8550, Japan

Phone: +81-43-484-1534

Facsimile: +81-43-484-3969

Date Established

October 15, 1998

Capital
100,000,000 JPYen
Shareholders
Fujikura Ltd. (97.5%)  Suzuki Giken Co.,Ltd.
Representative

President & COOKazuyuki Nihonyanagi

Main Business Areas
Development, Manufacturing and Sale of medical Ultra-Thin endoscopes
and other medical devices
Membership
Japan Ophthalmic Instruments Association
Medical Technology Associate of Japan
Japan Medical-Optical Eqipment Industrial Association
The Japan Fair Trade Council of the Medical Devices Industry
Access
Head office

[ MAP ]


Tokyo office
Tokyo Metro Tozai Line:
3 minites walk from Takebashi Station (Exit #3b)

[ MAP ]

BACK to TOP

HISTORY

Oct/1998
D-Base Japan Co., Ltd. was established for development and sale of medical devices applying new technology and medical digital systems
Nov/1998
D-Base Japan launched a portable endoscope co-developed with Sumita Optical Glass, Inc.
Mar/2000
D-Base Japan inherited technology of manufacturing ultra-thin fiberscopes from Medical Science Co., Ltd.
Dec/2000
D-Base Japan relocated its head office to Bunkyo-ku, Tokyo; D-Base Japan was renamed FiberTech Co., Ltd.
Sep/2001
FiberTech was qualified under the Small and Medium Enterprise Creative Endeavors Promotion Law for the development of the video laryngoscope
Oct/2001
FiberTech increased its capital to 25,500,000 JPYen through a third-party allocation of shares
Jan/2002
FiberTech increased its capital to 56,500,000 JPYen through a third-party allocation of shares
Mar/2002
FiberTech launched an angioscope (outside diameter or OD: 0.75mm)
Jul/2002
FiberTech entered into a comprehensive distribution agreement with Vision-Sciences, Inc. (USA), and started distribution of EndoSheath System (sheaths against infection for endoscopes)
Dec/2002
FiberTech increased its capital to 236,000,000 JPYen through a third-party allocation of shares
Jul/2003
FiberTech launched an ultra-thin angioscope (OD: 0.5mm)
Feb/2004
FiberTech was certified under ISO 13485
Apr/2004
FiberTech established Sakura Research Center in Sakura City, Chiba
Oct/2004
FiberTech became a wholly owned subsidiary of Internet Research Institute, Inc. (IRI) through a share exchange
Oct/2004
FiberTech relocated its head office to Chiyoda-ku, Tokyo
Oct/2004
FiberTech won the grand prize at “Tokyo Venture Technology Prize 2004”
Nov/2004
FiberTech increased its capital to 336,625,000 JPYen through shareholder allotment
Feb/2005
FiberTech was certified under ISO 9001
Oct/2005
FiberTech increased its capital to 424,125,000 JPYen through shareholder allotment
Dec/2006
FiberTech increased its capital to 489,120,000 JPYen through shareholder allotment
Jul/2007
FiberTech became a group company of Fujikura Ltd. through a share transfer
Jul/2008
FiberTech reduce its legal capital to 100mill Yen without any refund
Nov/2009
FiberTech established its satellite office in Fukuoka, Kyushu
Apr/2012
FiberTech started manufacturing of Optical Applied Products
May/2012
FiberTech relocated its head office within Chiyoda-ku, Tokyo
May/2014
Fibertech changed registration address of the company to Sakura-shi, Chiba
July/2014
FiberTech relocated its Tokyo Office within Chiyoda-ku, Tokyo

BACK to TOP

BUSINESS

Since the company was established in 1998, FiberTech has put the ultra-thin endoscopes that enable “seeing the invisible with minimal invasion” at the core of its product line and has continuously strived for realization of serving patient-friendly medical devices. And now, we are taking the new step to become the leading “Product and Technology Integrator” in the medical field. Based on deep and wide knowledge and experience acquired through medical device business, we will take advantage of our core micro-technology and also applied optical technology to realize new applications. We will offer new medical products that meet market needs not only by developing and implementing innovative technologies, but also by revitalizing potential valuable technologies. We believe this will allow us to contribute to the development of next-generation medical technologies and establish our identity in society.

What we are addressing next are the wide range of product portfolio to aim one-stop solution from the inspection/the diagnosis to treatment, advanced level technology of image processing, etc.

Our activities are not limited to the Japan market. We are making steady steps toward international markets to have our products help patients and medical professionals throughout the world.

Keeping our corporate slogan “C & C (Courage and Challenge)” in mind, we are determined to venture into new fields of business.

BACK to TOP

QUALITY MANAGEMENT

ISO 9001:2008
Design, development, manufacture and servicing of sterile and non sterile fiber endoscopes including peripheral equipment (imaging systems for fiber endoscopes) and medical devices for surgical applications (laser related devices)

Manufacture and servicing of optical application devices (image related devices, large core related devices and bundle related devices)
ISO 13485:2003
EN ISO 13485:2012
Design, development, manufacture, and servicing of sterile and non sterile fiber endoscopes including peripheral equipment (imaging systems for fiber endoscopes) and medical devices for surgical applications (laser related devices)

BACK to TOP

Transparency Guidelines for the Medical Device Industry and its Relationships with Medical Institutions and Other Organizations

Objective
FiberTech Co., Ltd. follow “Transparency Guidelines for the Medical Device Industry and its Relationships with Medical Institutions and Other Organizations” which were established by The Japan Federation of Medical Devices Associations and disclosure expenses to medical institutions, medical personnel, academies and societies for the study in our business activities.
Disclosure method
We disclosure on our website.
Timing of disclosure
Expenses to medical institutions, medical personnel, academies and societies for the study in fiscal year 2015 (2015 April – 2016 March) is disclosed at an appropriate timing after the closing of the financial results. After fiscal year 2015, annual amount will be updated and will be disclosed.
Subject of disclosure
The subject of expenses to disclosure is research and develop expenses, academic research support expenses, manuscript writing fees, expenses related to information provision and other expenses. Details are in of scope of disclosure.

Details are in of scope of disclosure. [ PDF ]

BACK to TOP

  • Medical Endoscope
  • Medical Equipment